Cargando…
Scalable preparation of osteogenic micro‐tissues derived from hESC‐derived immunity‐and‐matrix‐regulatory cells within porous microcarriers in suspension culture
Bone defects (BDs), a prevalent clinically refractory orthopaedic disease, presently have no effective treatments. Mesenchymal stem cells (MSCs) can differentiate into osteoblasts and serve as potential seed cells for bone tissue engineering for BD treatment. However, the feasibility of using MSCs a...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10212705/ https://www.ncbi.nlm.nih.gov/pubmed/37199065 http://dx.doi.org/10.1111/cpr.13466 |